The Association between Frailty Status and Blood Pressure Variability in Chronic Kidney Disease Patients Undergoing Hemodialysis

Author:

Wardani Ariani IntanORCID,Lydia Aida,Harimurti Kuntjoro,Rinaldi Ikhwan,Nugroho Pringgodigdo,Mansjoer Arif,Koesnoe Sukamto,Shatri HamzahORCID

Abstract

BACKGROUND: The high mortality rate of patients with chronic kidney disease undergoing hemodialysis (CKD-HD) is influenced by the high number of cardiovascular-induced death and blood pressure variability (BPV). AIM: The aim of this study is to understand the association between frailty status and intradialytic BPV. METHODS: This is a cross-sectional study examining patients with CKD who underwent hemodialysis (HD) at Dr. Cipto Mangunkusumo National General Hospital from August to September 2022. BPV was calculated using the average real variability method and frailty status was assessed based on Frailty Index 40 Item. The association between frailty and systolic BPV was analyzed using the Chi-Square test, followed by logistic regression analysis to exclude the influence of the confounding variable. RESULTS: Out of 88 subjects recruited, 28.4% (95% CI: 18.98–37.82) were considered frail, 55.7% (95% CI: 45.32–66.08) were pre-frail, and 15.9% (95% CI: 8.26–23.54) were robust. The mean intradialytic BPV was 10.11 (8.60–13.35). It was found that the trend increased along with the rising frailty status, and the mean difference of intradialytic systolic BPV based on the results of Kruskal–Wallis testing had statistical significance. The result of the multivariate analysis revealed an increase in BPV prevalence in patients with pre-frailty (adjusted PR = 1.606, 95% CI: 0.681–3.787) and frailty (adjusted PR = 1.886 (95% CI: 0.783–4.545). CONCLUSION: Statistically, there is no association between frailty status and intradialytic BPV. However, clinically, a dose-response association was observed, indicating that the higher the frailty status, the higher the prevalence ratio for the occurrence of high BPV.

Publisher

Scientific Foundation SPIROSKI

Subject

General Medicine

Reference33 articles.

1. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709-33. https://doi.org/10.1016/S0140-6736(20)30045-3.

2. Afiatin A, Suhaimi N, Tessy M. Indonesian Renal Registry (IRR) 2020. [PowerPoint Presentation]. Indonesia: Indonesian Society of Nephrology; 2021. Available from: https://www. indonesianrenalregistry.org [Last accessed on 2022 July 12].

3. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2020 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States; 2022. Available from: https://adr.usrds.org/2020 [Last accessed on 2022 July 12].

4. Afiatin A, Agustian D, Wahyudi K, Riono P, Roesli RM. Survival analysis of chronic kidney disease patients with hemodialysis in West Java, Indonesia, year 2007 - 2018. Bandung Med J. 2020;52(3):172-9.

5. Kovesdy CP. Epidemiology of chronic kidney disease: An update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11. https://doi.org/10.1016/j.kisu.2021.11.003 PMid:35529086

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3